# Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries

> **NCT03944473** · PHASE4 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Ambulatory Difficulty

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT03944473
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06-20
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-07-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Stopped before IRB approval
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03944473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03944473, "Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03944473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*